OMERS ADMINISTRATION Corp Purchases New Stake in Delcath Systems, Inc. (NASDAQ:DCTH)

OMERS ADMINISTRATION Corp bought a new stake in shares of Delcath Systems, Inc. (NASDAQ:DCTH - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 48,000 shares of the company's stock, valued at approximately $578,000. OMERS ADMINISTRATION Corp owned approximately 0.15% of Delcath Systems at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Vivo Capital LLC raised its stake in shares of Delcath Systems by 71.4% in the 4th quarter. Vivo Capital LLC now owns 1,708,579 shares of the company's stock worth $20,571,000 after buying an additional 711,574 shares in the last quarter. Gilder Gagnon Howe & Co. LLC bought a new stake in shares of Delcath Systems in the 4th quarter worth $7,371,000. Jane Street Group LLC raised its stake in shares of Delcath Systems by 1,364.6% in the 4th quarter. Jane Street Group LLC now owns 178,797 shares of the company's stock worth $2,153,000 after buying an additional 166,589 shares in the last quarter. Silverarc Capital Management LLC bought a new stake in shares of Delcath Systems in the 4th quarter worth $1,870,000. Finally, Apis Capital Advisors LLC bought a new stake in shares of Delcath Systems in the 4th quarter worth $1,618,000. Institutional investors own 61.12% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have recently commented on DCTH. HC Wainwright boosted their price objective on Delcath Systems from $24.00 to $29.00 and gave the stock a "buy" rating in a research note on Friday. Wall Street Zen raised Delcath Systems from a "buy" rating to a "strong-buy" rating in a research note on Saturday. Four equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Buy" and an average price target of $24.00.

Delcath Systems Trading Down 0.2%

Shares of Delcath Systems stock traded down $0.04 on Friday, reaching $16.11. 551,896 shares of the company were exchanged, compared to its average volume of 372,067. The stock has a fifty day moving average price of $13.05 and a 200-day moving average price of $12.98. The firm has a market capitalization of $561.05 million, a price-to-earnings ratio of -11.93 and a beta of 0.72. Delcath Systems, Inc. has a fifty-two week low of $6.33 and a fifty-two week high of $18.23.

Delcath Systems (NASDAQ:DCTH - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.10 by ($0.07). The company had revenue of $19.80 million for the quarter, compared to analyst estimates of $16.83 million. Delcath Systems had a negative return on equity of 338.16% and a negative net margin of 150.70%. On average, equities analysts anticipate that Delcath Systems, Inc. will post -0.79 earnings per share for the current fiscal year.

About Delcath Systems

Delcath Systems, Inc, an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.